FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308705276> ?p ?o ?g. }

• W4308705276 endingPage "41967" @default.
• W4308705276 startingPage "41956" @default.
• W4308705276 abstract "Recently, we detected a previously unknown Ser-Pro-Cys (SPC) tripeptide in the blood serum of multiple sclerosis patients. Its role as a biomarker of the autoimmune disease was suggested, although its origin and real biological activity remained unclear. Here, we created a biocompatible PEGylated comb-like polymer that was used as a platform for covalent immobilization of the SPC, which provided a possibility to explore the biological activity of this tripeptide. This macromolecular conjugate was synthesized via a reaction of the terminal epoxide group of the biocompatible copolymer of dimethyl maleate (DMM) and polyethylene glycol methyl ether methacrylate (PEGMA) with the amino group of the SPC tripeptide. Unexpectedly, the resulting conjugate containing SPC demonstrated anticancer activity in vitro. It possessed pro-apoptotic action toward human tumor cells, while there was no cytotoxic effect of that conjugate toward normal lymphocytes of human peripheral blood. The detected biological effects of the created conjugate inspired us to carry out a thorough study of structural and colloidal-chemical characteristics of this surface-active copolymer containing side PEG chains and a terminal nontoxic synthetic fragment. The copolymer composition, in particular, the content of the peptide fragment, was determined via elemental analysis and NMR spectroscopy. At CMC, it formed polymeric micelle-like structures with a hydrodynamic diameter of 180 ± 60 nm. The conjugation of the peptide fragment to the initial comb-like copolymer caused a change of zeta-potential of the formed micelle-like structures from -0.15 to 0.32 mV. Additional structural modification of the created polymeric nanoplatform was performed via attachment of fluorescein isothiocianate (FITC) dye that permitted monitoring of the behavior of the bioactive SPC-functionalized conjugate in the treated tumor cells. Its penetration into those cells and localization in their cytoplasm were revealed. The principal novelty of this study consists in finding that covalent conjugation of two nontoxic compounds-SPC tripeptide and comb-like PEGylated polymer-led to an unexpected synergy which appeared in the distinct cytotoxic action of the macromolecular complex toward human tumor cells. A potential role of peculiarities of the colloidal-chemical properties of the novel conjugate in its cytotoxic effect are discussed. Thus, synthesized comb-like PEGylated polymers can provide a prospective nanoplatform for drug delivery in anticancer chemotherapy." @default.
• W4308705276 created "2022-11-14" @default.
• W4308705276 creator A5005178571 @default.
• W4308705276 creator A5015868396 @default.
• W4308705276 creator A5024041808 @default.
• W4308705276 creator A5034357412 @default.
• W4308705276 creator A5041343915 @default.
• W4308705276 creator A5043546894 @default.
• W4308705276 creator A5047207873 @default.
• W4308705276 creator A5054846306 @default.
• W4308705276 creator A5063890719 @default.
• W4308705276 creator A5079906436 @default.
• W4308705276 creator A5085237177 @default.
• W4308705276 creator A5087276527 @default.
• W4308705276 date "2022-11-11" @default.
• W4308705276 modified "2023-10-17" @default.
• W4308705276 title "Covalent Conjugate of Ser-Pro-Cys Tripeptide with PEGylated Comb-Like Polymer as Novel Killer of Human Tumor Cells" @default.
• W4308705276 cites W1988969017 @default.
• W4308705276 cites W2027137358 @default.
• W4308705276 cites W2088659772 @default.
• W4308705276 cites W2116240218 @default.
• W4308705276 cites W2151213561 @default.
• W4308705276 cites W2463447483 @default.
• W4308705276 cites W2519786994 @default.
• W4308705276 cites W2809400919 @default.
• W4308705276 cites W2905732498 @default.
• W4308705276 cites W2937346106 @default.
• W4308705276 cites W3005318734 @default.
• W4308705276 cites W3016192732 @default.
• W4308705276 cites W3046431635 @default.
• W4308705276 cites W3086803898 @default.
• W4308705276 cites W3095597892 @default.
• W4308705276 cites W3134118369 @default.
• W4308705276 cites W3188373780 @default.
• W4308705276 cites W3200232214 @default.
• W4308705276 cites W4211061739 @default.
• W4308705276 doi "https://doi.org/10.1021/acsomega.2c03611" @default.
• W4308705276 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36440124" @default.
• W4308705276 hasPublicationYear "2022" @default.
• W4308705276 type Work @default.
• W4308705276 citedByCount "0" @default.
• W4308705276 crossrefType "journal-article" @default.
• W4308705276 hasAuthorship W4308705276A5005178571 @default.
• W4308705276 hasAuthorship W4308705276A5015868396 @default.
• W4308705276 hasAuthorship W4308705276A5024041808 @default.
• W4308705276 hasAuthorship W4308705276A5034357412 @default.
• W4308705276 hasAuthorship W4308705276A5041343915 @default.
• W4308705276 hasAuthorship W4308705276A5043546894 @default.
• W4308705276 hasAuthorship W4308705276A5047207873 @default.
• W4308705276 hasAuthorship W4308705276A5054846306 @default.
• W4308705276 hasAuthorship W4308705276A5063890719 @default.
• W4308705276 hasAuthorship W4308705276A5079906436 @default.
• W4308705276 hasAuthorship W4308705276A5085237177 @default.
• W4308705276 hasAuthorship W4308705276A5087276527 @default.
• W4308705276 hasBestOaLocation W43087052761 @default.
• W4308705276 hasConcept C11268172 @default.
• W4308705276 hasConcept C134306372 @default.
• W4308705276 hasConcept C15920480 @default.
• W4308705276 hasConcept C167392928 @default.
• W4308705276 hasConcept C178790620 @default.
• W4308705276 hasConcept C180577832 @default.
• W4308705276 hasConcept C184651966 @default.
• W4308705276 hasConcept C185592680 @default.
• W4308705276 hasConcept C188027245 @default.
• W4308705276 hasConcept C197336794 @default.
• W4308705276 hasConcept C204389451 @default.
• W4308705276 hasConcept C21951064 @default.
• W4308705276 hasConcept C2776964284 @default.
• W4308705276 hasConcept C2779149719 @default.
• W4308705276 hasConcept C2779281246 @default.
• W4308705276 hasConcept C33923547 @default.
• W4308705276 hasConcept C521977710 @default.
• W4308705276 hasConcept C55493867 @default.
• W4308705276 hasConcept C67407626 @default.
• W4308705276 hasConceptScore W4308705276C11268172 @default.
• W4308705276 hasConceptScore W4308705276C134306372 @default.
• W4308705276 hasConceptScore W4308705276C15920480 @default.
• W4308705276 hasConceptScore W4308705276C167392928 @default.
• W4308705276 hasConceptScore W4308705276C178790620 @default.
• W4308705276 hasConceptScore W4308705276C180577832 @default.
• W4308705276 hasConceptScore W4308705276C184651966 @default.
• W4308705276 hasConceptScore W4308705276C185592680 @default.
• W4308705276 hasConceptScore W4308705276C188027245 @default.
• W4308705276 hasConceptScore W4308705276C197336794 @default.
• W4308705276 hasConceptScore W4308705276C204389451 @default.
• W4308705276 hasConceptScore W4308705276C21951064 @default.
• W4308705276 hasConceptScore W4308705276C2776964284 @default.
• W4308705276 hasConceptScore W4308705276C2779149719 @default.
• W4308705276 hasConceptScore W4308705276C2779281246 @default.
• W4308705276 hasConceptScore W4308705276C33923547 @default.
• W4308705276 hasConceptScore W4308705276C521977710 @default.
• W4308705276 hasConceptScore W4308705276C55493867 @default.
• W4308705276 hasConceptScore W4308705276C67407626 @default.
• W4308705276 hasIssue "46" @default.
• W4308705276 hasLocation W43087052761 @default.
• W4308705276 hasLocation W43087052762 @default.
• W4308705276 hasLocation W43087052763 @default.
• W4308705276 hasOpenAccess W4308705276 @default.

• next